Ashley Yeo
Healthcare Editor
Healthcare Editor
UK
+21 year(s) experience
Medtech Insight: 世界の医療機器・医療技術の最新情報
Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.
Topic brexit Medtech-Brexit
Medtech Insight: 世界の医療機器・医療技術の最新情報
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
Medtech Insight: 世界の医療機器・医療技術の最新情報
High level EU-UK negotiations have yet to deliver a free trade deal. Meanwhile, the MHRA has issued more guidance for medtechs accessing the UK market in 2021.
Topic EU Medtech-Brexit Brexit
Medtech Insight: 世界の医療機器・医療技術の最新情報
Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.
Topic cancer policy-and-regulation
Medtech Insight: 世界の医療機器・医療技術の最新情報
New MHRA guidance says the EU CE marking will continue to be used for devices and diagnostics in Great Britain until June 2023, and thereafter a standalone regulatory system will come into place.
Topic Medtech-Brexit Regulation
Medtech Insight: 世界の医療機器・医療技術の最新情報
Securing a favorable post-Brexit free trade agreement with the US is the principal aim of the UK’s Department for International Trade, and the UK medtech industry is pressing its case for closer business links with its largest non-EU trading partner.
Medtech Insight: 世界の医療機器・医療技術の最新情報
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.
Topic EU Medtech-Brexit Regulation brexit
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
As night turned to day on June 24, it became clearer by the hour that the unthinkable had happened, and the UK’s long and acrimonious debate about its 43-year membership of the European Union had ended in a victory for the Leave group. The local health care products industries made their views clear some weeks ago, but today and in the months to come, they will have to confront a Plan B that was never in the plans.
Topic Market Access Brexit
Medtech Insight: 世界の医療機器・医療技術の最新情報
As promised in mid-April, and just a month away from the UK’s yes/no vote on continued membership of the EU, the UK ABHI has completed and released a survey of its members’ views on this theme – its second within the past year.
Topic Brexit
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
The use of virtual, real-time and at-home testing to provide clinical trials data has been steadily gaining the interest of the health care industry. COVID-19 has put this opportunity into sharper focus, says CNS trials technology developer Cambridge Cognition, which is now adding a voice option to its portfolio.
Topic Coronavirus clinical-trials
Medtech Insight: 世界の医療機器・医療技術の最新情報
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Medtech Insight: 世界の医療機器・医療技術の最新情報
The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.
Topic medtech
Medtech Insight: 世界の医療機器・医療技術の最新情報
Medtech regulatory fees in the Philippines are being increased for the first time since 2001. The country's FDA says the new fees will support quality improvements.
Topic Policy and regulation
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
Johnson & Johnson's DePuy Synthes orthopedic business has taken a measured view of digital and robotic capabilities, rather than acquiring assets that perhaps do not fully meet its strategic needs. For the business's global R&D head Euan Thomson, any new technology must augment the group's abilities to drive meaningful outcomes.
Topic digital-health
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.
Topic digital-health
Medtech Insight: 世界の...
29 Jul 2021
Medtech Insight: 世界の...
15 Jul 2021
In Vivo: 医療用医薬品・医療機器...
15 Jul 2021
Medtech Insight: 世界の...
12 Jul 2021
Medtech Insight: 世界の...
03 Jun 2021
Medtech Insight: 世界の...
01 Jun 2021
Medtech Insight: 世界の...
01 Jun 2021
Medtech Insight: 世界の...
27 May 2021
Medtech Insight: 世界の...
18 May 2021
Medtech Insight: 世界の...
06 May 2021
In Vivo: 医療用医薬品・医療機器...
04 May 2021
Medtech Insight: 世界の...
29 Apr 2021
Medtech Insight: 世界の...
15 Apr 2021
In Vivo: 医療用医薬品・医療機器...
01 Apr 2021
Medtech Insight: 世界の...
11 Mar 2021